93 related articles for article (PubMed ID: 15220166)
21. The effect of naloxone on ketamine-induced effects on hyperalgesia and ketamine-induced side effects in humans.
Mikkelsen S; Ilkjaer S; Brennum J; Borgbjerg FM; Dahl JB
Anesthesiology; 1999 Jun; 90(6):1539-45. PubMed ID: 10360849
[TBL] [Abstract][Full Text] [Related]
22. Delayed postoperative latent pain sensitization revealed by the systemic administration of opioid antagonists in mice.
Campillo A; Cabañero D; Romero A; García-Nogales P; Puig MM
Eur J Pharmacol; 2011 Apr; 657(1-3):89-96. PubMed ID: 21300053
[TBL] [Abstract][Full Text] [Related]
23. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
Dunbar SA; Karamian I; Zhang J
Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
[TBL] [Abstract][Full Text] [Related]
24. Synergistic interaction between ketamine and magnesium in lowering body temperature in rats.
Vučković SM; Savić Vujović KR; Srebro DP; Medić BM; Vučetić CS; Prostran MŠ; Prostran MŠ
Physiol Behav; 2014 Mar; 127():45-53. PubMed ID: 24486328
[TBL] [Abstract][Full Text] [Related]
25. Tramadol-induced hyperalgesia and its prevention by ketamine in rats: A randomised experimental study.
Abreu M; Aguado D; Benito J; García-Fernández J; Gómez de Segura IA
Eur J Anaesthesiol; 2015 Oct; 32(10):735-41. PubMed ID: 26295750
[TBL] [Abstract][Full Text] [Related]
26. Effects of different sufentanil target concentrations on the MAC
Guo Y; Wang D; Yang X; Jiang P; Xu J; Zhang G
BMC Anesthesiol; 2020 Sep; 20(1):239. PubMed ID: 32957929
[TBL] [Abstract][Full Text] [Related]
27. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
28. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
29. The effect of ketamine on the MACBAR of sevoflurane in dogs.
Love L; Egger C; Rohrbach B; Cox S; Hobbs M; Doherty T
Vet Anaesth Analg; 2011 Jul; 38(4):292-300. PubMed ID: 21627754
[TBL] [Abstract][Full Text] [Related]
30. Role of mu-opioid and NMDA receptors in the development and maintenance of repeated swim stress-induced thermal hyperalgesia.
Suarez-Roca H; Silva JA; Arcaya JL; Quintero L; Maixner W; Pinerua-Shuhaibar L
Behav Brain Res; 2006 Feb; 167(2):205-11. PubMed ID: 16214233
[TBL] [Abstract][Full Text] [Related]
31. Paradoxical hyperalgesia induced by mu-opioid receptor agonist endomorphin-2, but not endomorphin-1, microinjected into the centromedial amygdala of the rat.
Terashvili M; Wu HE; Schwasinger E; Tseng LF
Eur J Pharmacol; 2007 Jan; 554(2-3):137-44. PubMed ID: 17112504
[TBL] [Abstract][Full Text] [Related]
32. Amitriptyline, minocycline and maropitant reduce the sevoflurane minimum alveolar concentration and potentiate remifentanil but do not prevent acute opioid tolerance and hyperalgesia in the rat: a randomised laboratory study.
Aguado D; Abreu M; Benito J; García-Fernández J; Gómez de Segura IA
Eur J Anaesthesiol; 2015 Apr; 32(4):248-54. PubMed ID: 24849503
[TBL] [Abstract][Full Text] [Related]
33. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents.
Finkel JC; Pestieau SR; Quezado ZM
J Pain; 2007 Jun; 8(6):515-21. PubMed ID: 17434801
[TBL] [Abstract][Full Text] [Related]
34. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
35. Remifentanil added to sufentanil-sevoflurane anesthesia suppresses hemodynamic and metabolic stress responses to intense surgical stimuli more effectively than high-dose sufentanil-sevoflurane alone.
Bergmann I; Szabanowski T; Bräuer A; Crozier TA; Bauer M; Hinz JM
BMC Anesthesiol; 2015; 15(1):3. PubMed ID: 25670917
[TBL] [Abstract][Full Text] [Related]
36. Antinociceptive mechanisms of platycodin D administered intracerebroventricularly in the mouse.
Choi SS; Han EJ; Lee TH; Lee JK; Han KJ; Lee HK; Suh HW
Planta Med; 2002 Sep; 68(9):794-8. PubMed ID: 12357389
[TBL] [Abstract][Full Text] [Related]
37. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
Juni A; Klein G; Kest B
Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
[TBL] [Abstract][Full Text] [Related]
38. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine.
Koyuncuoglu H; Nurten A; Yamantürk P; Nurten R
Pharmacol Res; 1999 Apr; 39(4):311-9. PubMed ID: 10208762
[TBL] [Abstract][Full Text] [Related]
39. Non-nociceptive environmental stress induces hyperalgesia, not analgesia, in pain and opioid-experienced rats.
Rivat C; Laboureyras E; Laulin JP; Le Roy C; Richebé P; Simonnet G
Neuropsychopharmacology; 2007 Oct; 32(10):2217-28. PubMed ID: 17299508
[TBL] [Abstract][Full Text] [Related]
40. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
